Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DNB-001 in Ocular Hypertension
NCT00683501Phase 2Completed
- Sponsor
- Danube Pharmaceuticals
- Start
- Oct 2007
- Primary completion
- Aug 2008
- Modality
- Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of DNB-001 in ocular hypertension, sponsored by Danube Pharmaceuticals. Started Oct 2007; status: completed.
02
Drugs
DNB-001
03
Conditions
ocular hypertension
Beyond the preview
Go deeper on NCT00683501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00683501.